Esophageal Cancer
Showing NaN - NaN of 72
Esophageal Cancer, Gastric Adenocarcinoma, HER2 Gene Mutation Trial in United States (Pembrolizumab, Trastuzumab)
Not yet recruiting
- Esophageal Cancer
- +2 more
-
Baltimore, Maryland
- +8 more
Nov 3, 2023
Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified
Recruiting
- Endometrial Cancer
- +8 more
- Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
-
Orlando, Florida
- +21 more
Feb 2, 2023
Retrospective Review of Esophageal Cancer at MSKCC
Recruiting
- Esophageal Cancer
- Esophagus Cancer
- Esophagectomy
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Jan 23, 2023
Fragments for Early Interception - Lung Cancer Training Study
Recruiting
- Lung Cancer
- +8 more
- Blood Sample Collection
-
New York, New York
- +1 more
Nov 28, 2022
Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)
Completed
- Prostate Cancer
- +4 more
- NY-ESO-1 Plasmid DNA Cancer Vaccine
-
New York, New York
- +1 more
Oct 3, 2022
Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)
Recruiting
- Esophageal Cancer
- Esophagogastric Junction Cancer
- Autologous genetically modified ADP-A2M4CD8 cells
-
Duarte, California
- +33 more
Aug 23, 2022
Intestinal Microbiome, Oral Microbiome, and Whole Blood
Recruiting
- Gastrointestinal Cancer
- +6 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 5, 2022
Esophageal Adenocarcinoma, Esophageal Cancer, HER-2 Protein Overexpression Trial in New York, Providence (Nivolumab, Trastuzumab
Not yet recruiting
- Esophageal Adenocarcinoma
- +3 more
- Nivolumab
- Trastuzumab deruxtecan
-
New York, New York
- +1 more
Jul 28, 2022
Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)
Recruiting
- Pancreatic Cancer
- +15 more
-
Grand Rapids, Michigan
- +2 more
Jul 18, 2022
Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)
Recruiting
- Esophagogastric Tumors
- +9 more
-
Basking Ridge, New Jersey
- +6 more
Jul 8, 2022
Esophageal Cancer, Gastric Cancer Trial in United States (Afatinib and Paclitaxel)
Active, not recruiting
- Esophageal Cancer
- Gastric Cancer
- Afatinib and Paclitaxel
-
Los Angeles, California
- +8 more
Mar 18, 2022
Kidney Cancer, Head Neck Cancer, Breast Cancer Trial in New York (177Lu-J591)
Completed
- Kidney Cancer
- +8 more
-
New York, New YorkWeill Cornell Medical College
Feb 1, 2022
Tissue & Blood From Patients w/ Benign & Malignant Tumors of
Active, not recruiting
- Esophageal Cancer
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 12, 2021
Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer Trial in United States (drug, procedure, radiation)
Active, not recruiting
- Adenocarcinoma of the Gastroesophageal Junction
- Esophageal Cancer
- Oxaliplatin
- +7 more
-
Mountain View, California
- +67 more
Oct 5, 2021
Esophageal Cancer Trial in New York (other, device, procedure)
Recruiting
- Esophageal Cancer
- Injection of indocyanine green (ICG)dye
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 29, 2021
Clinical Management of Esophageal Adenocarcinoma (EAC)
Active, not recruiting
- Esophageal Cancer
- Adenocarcinoma
- serum and tissue mesothelin
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 1, 2021
Esophageal Cancer Trial in United States (cetuximab, ECF, IC)
Completed
- Esophageal Cancer
- cetuximab
- +3 more
-
Norwalk, Connecticut
- +226 more
Sep 2, 2021
Esophageal Cancer, Gastric Cancer Trial in United States (pembrolizumab, trastuzumab, capecitabine)
Active, not recruiting
- Esophageal Cancer
- Gastric Cancer
- pembrolizumab
- +5 more
-
Basking Ridge, New Jersey
- +7 more
Sep 17, 2021
Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))
Completed
- Gastric Adenocarcinoma
- +15 more
- Sacituzumab Govitecan-hziy (SG)
-
Aurora, Colorado
- +11 more
Aug 10, 2021
Following Minimally Invasive and Open Esophagectomy for
Completed
- Esophageal Cancer
- Quality of Life instruments, FACT-E, Symptom Assessment Scale, Brief Pain Inventory and Daily Analgesic Log
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 5, 2021
Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)
Completed
- Liver Cancer
- +9 more
- Early palliative care
-
La Jolla, California
- +22 more
Jul 22, 2021